And, you know, you're seeing an HCA do extremely well, 
TID shipments declined by 20% due to lower industrial activity in both Europe and the US. 
We also received ASI certification of our Neuf-Brisach facility under provisional COVID conditions in 202. 
which is why in the Phase IIA study over 28 days, we use the ELISA to assess RASP levels. 
Earlier this month, the Florida Public Service Commission, approved Gulf Powers request to record cost attributable to COVID-19, including bad debt expense, 
The project is under the investment tax credit ITC regime, and has secured a 30 year PPA with Georgia Power. 
Now that the PG&E bankruptcy has been favorably resolved, we will no longer provide <inaudible> expectations including contributions… E-excluding the contributions from the Desert Sunlight projects. 
Chris Parkinson asked for a COVID-19 update. His question is, 
Joc, we received a handful of questions on the balance sheet. Primarily focused on uses of pre castable. John Roberts asked 
Joc, we have the three questions related to China and phosphate. First Vincent Andrews asks, 
Given that the last 10 years of P&K shipments show some pattern lumpiness of potash, more than phosphates. 
I would like to take this opportunity to congratulate Craig Merrill on being appointed our permanent CFO. 
Thank you. Our next question is from Jon Block with Stifel. Please go ahead. 
The next question is coming from the line of Rob Pauli, Rob Pauline from Morgan Stanley. 
Your next question comes from Tycho Peterson with JP Morgan. Your line is open. 
Your next question comes from the line of Sharon Zackfia with William Blair. Please proceed with your question. 
That was component two of your question, Brandon. I think component three was Zalviso. And Pam, you can comment on that one as well as, we're continuing to study the regulatory parameters. 
With that, I will turn the call over to John Hartmann, our Chief Operating Officer and President of buybuy BABY. 
which often have a PPV in the range of 3% to 5%. 
will recognize the compelling value propositions and drive adoption of the first multi-cancer detection LDT available. 
For your information, concerning those factors has been provided in today's press release of 10-K and regular filings with the SEC. Now, I like to turn the call over to Fabio Sandri. 
Several HCS product lines, and most of PDX, is down as much as 50%, versus pre-pandemic levels. 
So we, we, we flag in the queue the IATA numbers, we also reference 
Coolers & Equipment net sales increased 27% to $124.20 million 
And now, I'd like to turn the call over to Chris Ahern. Chris? Thanks, Brendan, and thank you to everyone on today's call. We hope you and your families continue to be safe and healthy. 
We achieved NOI of 14.5 million and AFFO of $2.9 million or six cents per share. 
Our next question comes from the line of Ken Dasla with BMO. Please proceed with your question. Hey, good morning, everyone. 
Our next question comes from the line of John Baumgartner with Wells Fargo. Please proceed with your question. 
which aims at developing a hydrogen corridor from Southern Europe to the North, 
grade of Snam. 
We will continue to execute on our restructuring plans and are currently assessing our SGNA position relative to overall sales volumes in the environment. 
Yes. <crosstalk>. Michael, we lost you. No. Still here. Thanks, thanks for the comment. Thank you. And our next question is from Jason, um, Bednar with Piper Sandler. Please go ahead. 
our business generated 31% more EBDA this quarter than we did in the third quarter. 
roughly 60% of the CFM fleet is parked today. 
AS&I adjusted EBITDA of €33 million decreased by €26 million or 44% compared to last year. 
Joc, Steve Barnes would like more insight into our global soft rate demand outlook and its relationship to inventories swings specifically, 
Um, yeah, Brian, this is Steve Rasche. There's a, 
Uh, wondering in the orthodontic business, I mean, you- you've mentioned here a few times leveraging the CEREC installed base with clear aligners. Uh, 
Now we know that the manufacturing MEMS products in high volume is not easy. 
which we anticipate reflects an addressable market for NGS based oncology testing of $75 billion. 
So excluding BioPharma, battler was up 1% sequentially and four versus prior year. 
we refer all of you to the risk factors contained in ZAGG's annual report on Form 10-K and quarterly reports on Form 10-Q by the Securities and Exchange Commission. 
We expect to generate substantial free cashflow throughout the balance of the year, which should result in a decreasing debt balance and help us achieve our target of being below one times debt to EBITAX for the year. 
Adam Samuelson from Goldman Sachs, uh, in the second quarter, Mosaic was ahead of its 2021 targets and a number of its key cost KPIs. 
Joc, PJ <inaudible> also asked, With the recent rise of over $50 per time in DAP pricing, 
Now we believe that the growth of MicroEssentials will continue over the next quarter, driven by Mosaic for <inaudible> and also North America. 
In June, North America SBM sales were down 1.50% versus prior year June. 
The underlying combined ratio of 91.4%, which excludes the impacts of cats and PYD, 
What are the next steps? The development of the project will continue with a view to participating in CFD auction rounds in three to five years' time. 
bringing year-to-date free cash flow, excluding M&A and the ABL draw to over 45 million. 
You know, we continue to lead the industry in O&M cost, we continue to lead the industry in reliability and customer service, um, and the best way to keep doing that is execute. 
Additionally, we expect this significant reduction in utilization is likely to continue to pressure our CSA margins. 
Sam, can you just talk about maybe the OPEX trajectory over the next 12 months, again, to get to that, uh, 350, 375 number you noted? 
So from Q2 to Q3, as- as I mentioned, the most significant growth was in our mobile IOT group, right? 
Particular strengths in Cepheid's flu assay was driven by the combination of a more severe flu season and increased testing during the Coronavirus outbreak. 
I think the most obvious one and you called it out is T&E, right. So, uh, we're still working remotely and, and, and not traveling, 
This call is the property of AcelRx and any recording, reproduction or transmission of this call 
I was wondering about the promotion efforts to create visibility for, uh, NewsNation, as that is, you know, coming to the floor. 
the anticipated FNE margin expansion once all the production inefficiencies are sorted out? Um, what do you think the new margin profile looks like in a new normal? 
As a result of the size of the Cytiva acquisition and its impact on Danaher's overall core 
In addition, a large portion of our food service customers are also within the QSR segments, which has further dampened the impact across our fresh business unit models. 
you're gonna be emphasizing SureSmile principally in the GP channel? Or do you have a strategy to 
And as a reminder, Nexstar's only covenant is our first lien, uh, debt covenant, which is the formation for the quarter. 
And correct me if I'm wrong, but Amex has a, 
And for us, we know that a BOPUS order fulfilled by store is almost equivalent to a store by <inaudible> profitability. 
as we look out into 2021? Or is it still the existing Drinkware in cooler categories and just replenishment and the wholesale, and then sustain strengthen in DTC? 
Thank you. That's, that's very helpful. Um, and then just around your, your CapEx profile, um, 
Gross margin expanded 670 basis points to reach a record 59.10% while our adjusted SG&A rate decreased to 200 basis points. 
